Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcifediol versus cholecalciferol regimens for vitamin D deficiency in postmenopausal women
2017-004028-31Phase 4Active
- Sponsor
- Faes Farma
- Start
- Nov 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of calcifediol and cholecalciferol in Vitamin D deficiency (VDD) (2 arms), sponsored by Faes Farma. Primary endpoint: Percentage of patients achieving 25(OH)D above 30 ng/mL at 4 months. Started Nov 2017; status: active.
02
Drugs
calcifediolcholecalciferol
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2017-004028-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004028-31.